共 50 条
Risk of multiple drug interactions potentially linked to safety in patients receiving pangenotypic direct-acting antivirals for the treatment of hepatitis C
被引:0
|作者:
Turnes, J.
[1
]
Garcia-Herola, A.
[2
]
Morillo, R.
[3
]
Mendez, M.
[4
]
Rueda, M.
[4
]
Hernandez, C.
[6
]
Sicras-Mainar, A.
[5
]
Freismuth, A.
[7
]
机构:
[1] CHU Pontevedra, Dept Gastroenterol & Hepatol, Pontevedra, Spain
[2] Hosp Marina Baixa Villajoyosa, Dept Digest Med, Alicante, Spain
[3] AGS Sevilla, Hosp Valme, Hosp Pharm, Seville, Spain
[4] Gilead Sci SL, Med Affairs, Madrid, Spain
[5] Atrys Hlth, Hlth Econ & Outcomes Res, Barcelona, Spain
[6] Gilead Sci Europe Ltd, Global Med Affairs, London, England
[7] Gilead Sci Pty Ltd, Melbourne, Vic, Australia
关键词:
D O I:
暂无
中图分类号:
R57 [消化系及腹部疾病];
学科分类号:
摘要:
33
引用
收藏
页码:42 / 42
页数:1
相关论文